Preamble Merger Consideration. 3.1(i) Mergers.................................................... 2.1(a) Newco......................................................
Preamble Merger Consideration. Section 2.01(c) Notice of Adverse Recommendation................................Section 4.02(b) Parachute Grass Up Payment......................................Section 3.01(m) Parent.................................................................
Preamble Merger Consideration. 2.2(a) Merger Price.............................................................2.2(a) Non-Competition Agreement..................................................7.16
Preamble Merger Consideration. 3.1(b) Minimum Condition........................................................Annex A
Preamble Merger Consideration. .............. 2.1(c) Nasdaq National Market........................................ 2.1(c) Non-Dissenting Shares......................................... 2.1(g) Notice of Superior Proposal................................... 8.2(b) Out-of-Pocket Expenses........................................ 8.3(c) Parent........................................................ Introduction Parent Balance Sheet.......................................... 3.2(g) Parent Balance Sheet Date..................................... 3.2(g) Parent Benefit Plans.......................................... 3.2(t) Parent Charter Documents...................................... 3.2(e) Parent Common Stock........................................... 2.1(c) Parent Disclosure Schedule.................................... 3.2 Parent ERISA Affiliate ....................................... 3.2(t) Parent Financial Advisor...................................... 3.2(n) Parent Multiemployer Plans.................................... 3.2(t) Parent Regulatory Documents................................... 5.3(c) Parent Permits................................................ 3.2(l)
Preamble Merger Consideration. 3.2(a)(i) Offer . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.1(a) Offer Consideration . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.1(a) Offer Documents . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1.2 On a fully diluted basis . . . . . . . . . . . . . . . . . . . . . . . . 1.1(b) Option Consideration . . . . . . . . . . . . . . . . . . . . . . . . . . . 3.5
Preamble Merger Consideration. 1.2(b) Millennium Compliant.......................................................2.21 Option(s)................................................................1.3(a) OTS.........................................................................2.3
Preamble Merger Consideration. Section 2.1.7 Merger Effective Time..................................Section 2.1.2 Merger Sub..................................................
Preamble Merger Consideration. Section 2.01(c) Xxxxx'x ................................................ Section 3.2.02(f) New Plans .............................................. Section 5.10(b)
Preamble Merger Consideration. 2.1(d) Ongoing Clinical Programs....................................... 3.9(b) Ontogeny Exchange Ratio......................................... 2.1(b) Ontogeny Minimum Required Stockholder Vote...................... 7.12(b) Ontogeny Merger Consideration................................... 2.1(b) Ontogeny Common Stock........................................... 2.1(b) Ontogeny Preferred Stock........................................ 2.1(b) Ontogeny Required Stockholder Vote.............................. 7.12(a) Order........................................................... 10.3 Person.......................................................... 10.3
